Barry Gusterson

[citation needed] In 2000-2010 he was Professor of Pathology in Glasgow and was the project lead responsible for building the Wolfson Wohl Cancer Centre.

[9][10] Gusterson was educated at Colchester Royal Grammar School[citation needed] and obtained a BSc in Physiology at St Bartholomew’s Hospital.

[14] In 2000 he moved to Glasgow University, where he held a number of positions as Professor of Pathology, and Head of Forensic Science and Medicine, which won an £18.5 M contract from the Crown Office in 2006.

[4][7][16][17] The two cancer centres initiated by Gusterson were both developed as major fund-raising projects, in which he played a key role as the clinical lead.

[22][23] This led to the demonstration of the normal human tissue distribution[24] and overexpression and amplification of the Epidermal Growth Factor Receptors (EGFR) as a feature of squamous cell carcinomas.

This collaboration resulted in numerous publications, including the demonstration of c-erbB-2 (HER2) overexpression as a prognostic indicator in breast cancer [8] and suggested a cut point to define patients that would later benefit from Herceptin.